Loading
IARC estimates 8,400 new cancer cases and 5,721 cancer deaths in Laos in 2024; the commonest new cancers are liver and intrahepatic bile ducts, breast and trachea, bronchus and lung. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
Built partly from other countries' data. IARC's method code for Laos's incidence estimate is 5: rates based on incidence estimates or registry data from neighbouring countries. Read the figures as a regional estimate, not a count.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Liver and intrahepatic bile ducts | 1,861 | 31.0 | Hepatocellular carcinoma |
| Breast | 908 | 25.3 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Trachea, bronchus and lung | 734 | 12.4 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 726 | 11.9 | Colorectal cancer |
| Cervix uteri | 437 | 12.0 | Cervical cancer |
| Leukaemia | 339 | 4.7 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Non-Hodgkin lymphoma | 303 | 4.6 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Thyroid | 264 | 3.6 | Thyroid cancer |
| Brain, central nervous system | 206 | 2.9 | Glioma & glioblastoma |
| Lip, oral cavity | 203 | 3.4 |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Liver and intrahepatic bile ducts | 1,711 | 28.8 | Hepatocellular carcinoma |
| Trachea, bronchus and lung | 652 | 11.2 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Colorectum | 424 | 7.2 | Colorectal cancer |
| Breast | 395 | 11.3 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Cervix uteri | 243 | 6.8 | Cervical cancer |
| Leukaemia | 233 | 3.4 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
| Brain, central nervous system | 178 | 2.6 | Glioma & glioblastoma |
| Non-Hodgkin lymphoma | 131 | 2.1 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Stomach | 129 | 2.2 | Gastric & gastro-oesophageal junction cancer |
| Lip, oral cavity | 120 | 2.1 |
No trial record in OnCo lists a site in Laos. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Laos.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Laos is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Laos is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.